Optical Systems.
Advancing precision in optical sensing.
Qamcom develops high-performance optical and imaging systems that turn visual signals into actionable, reliable data.
By combining optics, electronics, image processing, AI, and embedded systems, we deliver complete solutions – from concept and prototyping to certified, production-ready instruments for medtech, industrial, and smart-infrastructure applications.
Experience.
Imaging partnership
Long-term partner in developing advanced imaging instruments for life science, diagnostics, and industrial inspection.
End-to-end delivery
Proven delivery of complete imaging instruments – from concept and prototyping to production-ready devices.
Optics expertise
Deep competence in optical design, camera systems, illumination, image processing, and embedded platforms.
Integrated algorithms
Extensive experience integrating advanced algorithms, calibration routines, and workflow-driven software.
Capabilities.
System design
Design of optics, sensors, illumination, mechanics, and electronics for complete imaging systems.
Image processing & AI
Signal and image processing, detection, classification, clustering, and analysis tailored to application needs.
Embedded imaging
Real-time imaging on edge and embedded systems with optimized pipelines and high data throughput.
Testing & validation
Optics, electronics, and EMC labs for performance, robustness, and compliance verification.
Related cases.
Mabtech EYRA – multiplex platform for vaccine and treatment development
Mabtech and Qamcom have collaborated on R&D since 2016, with the Iris and Astor platforms among the joint innovations. The EYRA platform marks a new chapter — a no-contact, automation-ready instrument built around a purpose-built confocal microscope, designed to redefine what's possible in multiplex analysis.
Making vaccine research more efficient and accurate.
Mabtech is a Swedish biotech company specialising in immunoassays for research and clinical diagnostics. Their FluoroSpot, ELISpot, and FociSpot readers are used worldwide in vaccine development and disease characterisation — and making them more accurate and easier to use directly translates to faster research outcomes.
3D imaging into more accurate surgeries
Hip surgery is one of the most common procedures in the world, yet most surgeons still rely on 2D X-rays for planning. Ortoma set out to change that with an AI-powered 3D imaging platform built on CT data — and turned to Qamcom for the software foundation.
Mabtech and Qamcom reinvent spot analysis with Mabtech Iris™
Mabtech is a Swedish biotech company. Founded by researchers in 1986, the Stockholm-based company is still run by researchers today and is internationally renowned for the tools it has developed for life science research, in particular in the field of immunology.
Mabtech is a leader in providing monoclonal antibodies and kits suitable for ELISpot and FluoroSpot analysis. Used by scientists worldwide to study immune responses in, for example, infectious diseases, cancers, allergies, transplantations and vaccine trials, the kits required third party readers for spot analysis. These readers lack the accuracy and precision needed in analysing spots secreted by single immune cells. Furthermore, they require calibration by the user – a step which will invariably add an element of subjectivity to the analysis and might therefore compromise the accuracy of the results.
Passionate about biomedical research and ensuring extreme accuracy in the discovery process, the Mabtech team felt that the situation could be improved.
"In order to realise our goal of fundamentally redefining spot reading technology, we needed a partner who could not only bring the technical skills we required, but who would also truly share our passion for the project. Qamcom did both, overcoming significant development challenges and delivering some brilliant enhancements to the product that even we had not thought of. Working with Qamcom, we were confident that there were no boundaries to what we could achieve together."
Christian Smedman, CTO, Mabtech
Contact us.
